<DOC>
<DOCNO>EP-0628555</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Substituted (2-oxo-1-benzimidazolinyl)-piperidines, process for their preparation and their use as antiretroviral agents.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K314427	A61K314427	A61K31445	A61K31445	A61K31495	A61K31495	A61K31505	A61K31505	A61K31535	A61K31535	A61K31675	A61K31675	A61P3100	A61P3112	A61P3118	C07D40100	C07D40104	C07D40114	C07D41700	C07D41714	C07F900	C07F96506	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P31	A61P31	A61P31	C07D401	C07D401	C07D401	C07D417	C07D417	C07F9	C07F9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to substituted (2-oxo-1-benzimidazolinyl) piperidines of the general formula (I) 
<
IMAGE
>
  in which the substituents have the meaning given in the description, process for their preparation and their use as antiretroviral agents.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
<APPLICANT-NAME>
BAYER AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BENDER WOLFGANG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
HAEBICH DIETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
HANSEN JUTTA DR
</INVENTOR-NAME>
<INVENTOR-NAME>
PAESSENS ARNOLD DR
</INVENTOR-NAME>
<INVENTOR-NAME>
RADDATZ SIEGFRIED DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ROEBEN WOLFGANG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
WILD HANNO DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BENDER, WOLFGANG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
HAEBICH, DIETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
HANSEN, JUTTA, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
PAESSENS, ARNOLD, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
RADDATZ, SIEGFRIED, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
ROEBEN, WOLFGANG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
WILD, HANNO, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
